Although the relationship between BCL7B expression status and poor prognosis was opposite in several cancers, it was also reported that gene set enrichment analysis (GSEA) suggested that BCL7B was notably associated with immune-related pathways in both property-type cancers [49]. Here, BCL7B is linked to cancer.